Abbott Laboratories (ABT)
Abbott Laboratories is a global healthcare company that produces a wide range of medical products and services, including pharmaceuticals, diagnostics, nutrition products, and medical devices. The company was founded in 1888 and is headquartered in Illinois, United States. Abbott Laboratories operates in over 150 countries and has a diverse workforce of around 100,000 employees.
Company Info
Highlights
$197.97B
$3.28
34.71
2.22
$41.22B
$22.55B
$10.76B
$99.24 - $121.00
$129.87
0.79%
2.58
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Abbott Laboratories, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Abbott Laboratories had a return of 4.36% year-to-date (YTD) and 7.07% in the last 12 months. Over the past 10 years, Abbott Laboratories had an annualized return of 11.49%, while the S&P 500 benchmark had an annualized return of 11.40%, indicating that Abbott Laboratories performed slightly bigger than the benchmark.
ABT
4.36%
-2.83%
9.96%
7.07%
7.19%
11.49%
^GSPC (Benchmark)
27.34%
3.47%
10.98%
28.71%
13.78%
11.40%
Monthly Returns
The table below presents the monthly returns of ABT, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 3.29% | 4.85% | -4.20% | -6.30% | -3.57% | 1.68% | 2.49% | 6.92% | 0.65% | -0.09% | 4.76% | 4.36% | |
| 2023 | 1.15% | -7.99% | -0.45% | 9.64% | -7.67% | 6.88% | 2.61% | -7.57% | -5.88% | -1.83% | 10.30% | 5.54% | 2.26% |
| 2022 | -9.12% | -5.37% | -1.87% | -3.72% | 3.49% | -7.50% | 0.62% | -5.69% | -5.74% | 2.74% | 8.73% | 2.05% | -20.68% |
| 2021 | 13.33% | -3.08% | 0.05% | 0.57% | -2.86% | -0.62% | 4.75% | 4.46% | -6.52% | 9.53% | -2.42% | 11.90% | 30.53% |
| 2020 | 0.75% | -11.60% | 2.44% | 17.19% | 3.07% | -3.68% | 10.50% | 8.77% | -0.58% | -3.10% | 2.96% | 1.17% | 28.04% |
| 2019 | 1.37% | 6.36% | 2.99% | -0.07% | -4.31% | 10.47% | 3.96% | -2.04% | -1.93% | 0.33% | 2.20% | 1.65% | 22.08% |
| 2018 | 9.44% | -2.94% | -0.68% | -2.52% | 5.85% | -0.88% | 7.94% | 1.98% | 9.75% | -5.64% | 7.41% | -2.32% | 29.06% |
| 2017 | 9.45% | 7.92% | -1.49% | -1.13% | 4.63% | 6.46% | 1.73% | 3.58% | 4.75% | 2.13% | 3.95% | 1.24% | 52.03% |
| 2016 | -15.19% | 2.35% | 7.98% | -6.44% | 1.88% | -0.81% | 14.54% | -6.10% | 0.64% | -6.62% | -2.98% | 0.89% | -12.32% |
| 2015 | -0.05% | 5.83% | -2.20% | 0.71% | 4.70% | 0.99% | 3.78% | -10.65% | -11.19% | 12.03% | 0.27% | -0.02% | 1.87% |
| 2014 | -3.82% | 8.51% | -3.19% | 1.19% | 3.28% | 2.22% | 3.54% | 0.29% | -1.54% | 5.37% | 2.11% | 1.15% | 20.08% |
| 2013 | 8.55% | -0.27% | 4.53% | 4.93% | -0.68% | -4.88% | 5.44% | -9.01% | -0.42% | 10.59% | 4.49% | 0.37% | 24.30% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of ABT is 51, suggesting that the investment has average results relative to other stocks in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Abbott Laboratories (ABT) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Abbott Laboratories provided a 1.95% dividend yield over the last twelve months, with an annual payout of $2.20 per share. The company has been increasing its dividends for 10 consecutive years.
| Period | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $2.20 | $2.04 | $1.88 | $1.80 | $1.44 | $1.28 | $1.12 | $1.06 | $1.04 | $0.96 | $0.88 | $0.56 |
Dividend yield | 1.95% | 1.85% | 1.71% | 1.28% | 1.32% | 1.47% | 1.55% | 1.86% | 2.71% | 2.14% | 1.95% | 1.46% |
Monthly Dividends
The table displays the monthly dividend distributions for Abbott Laboratories. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | $0.55 | $0.00 | $0.00 | $0.55 | $0.00 | $0.00 | $0.55 | $0.00 | $0.00 | $0.55 | $0.00 | $0.00 | $2.20 |
| 2023 | $0.51 | $0.00 | $0.00 | $0.51 | $0.00 | $0.00 | $0.51 | $0.00 | $0.00 | $0.51 | $0.00 | $0.00 | $2.04 |
| 2022 | $0.47 | $0.00 | $0.00 | $0.47 | $0.00 | $0.00 | $0.47 | $0.00 | $0.00 | $0.47 | $0.00 | $0.00 | $1.88 |
| 2021 | $0.45 | $0.00 | $0.00 | $0.45 | $0.00 | $0.00 | $0.45 | $0.00 | $0.00 | $0.45 | $0.00 | $0.00 | $1.80 |
| 2020 | $0.36 | $0.00 | $0.00 | $0.36 | $0.00 | $0.00 | $0.36 | $0.00 | $0.00 | $0.36 | $0.00 | $0.00 | $1.44 |
| 2019 | $0.32 | $0.00 | $0.00 | $0.32 | $0.00 | $0.00 | $0.32 | $0.00 | $0.00 | $0.32 | $0.00 | $0.00 | $1.28 |
| 2018 | $0.28 | $0.00 | $0.00 | $0.28 | $0.00 | $0.00 | $0.28 | $0.00 | $0.00 | $0.28 | $0.00 | $0.00 | $1.12 |
| 2017 | $0.27 | $0.00 | $0.00 | $0.27 | $0.00 | $0.00 | $0.27 | $0.00 | $0.00 | $0.27 | $0.00 | $0.00 | $1.06 |
| 2016 | $0.26 | $0.00 | $0.00 | $0.26 | $0.00 | $0.00 | $0.26 | $0.00 | $0.00 | $0.26 | $0.00 | $0.00 | $1.04 |
| 2015 | $0.24 | $0.00 | $0.00 | $0.24 | $0.00 | $0.00 | $0.24 | $0.00 | $0.00 | $0.24 | $0.00 | $0.00 | $0.96 |
| 2014 | $0.22 | $0.00 | $0.00 | $0.22 | $0.00 | $0.00 | $0.22 | $0.00 | $0.00 | $0.22 | $0.00 | $0.00 | $0.88 |
| 2013 | $0.14 | $0.00 | $0.00 | $0.14 | $0.00 | $0.00 | $0.14 | $0.00 | $0.00 | $0.14 | $0.00 | $0.00 | $0.56 |
Dividend Yield & Payout
Dividend Yield
Payout Ratio
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Abbott Laboratories. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Abbott Laboratories was 45.66%, occurring on Jul 23, 2002. Recovery took 621 trading sessions.
The current Abbott Laboratories drawdown is 15.78%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -45.66% | Feb 1, 2002 | 119 | Jul 23, 2002 | 621 | Jan 7, 2005 | 740 |
| -43.29% | Apr 26, 1999 | 220 | Mar 7, 2000 | 164 | Oct 27, 2000 | 384 |
| -35.2% | Mar 25, 1987 | 178 | Dec 4, 1987 | 415 | Jul 27, 1989 | 593 |
| -33.88% | Dec 28, 2021 | 451 | Oct 12, 2023 | — | — | — |
| -31.61% | Jan 23, 2020 | 42 | Mar 23, 2020 | 17 | Apr 16, 2020 | 59 |
Volatility
Volatility Chart
The current Abbott Laboratories volatility is 3.43%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Valuation
The Valuation section provides an assessment of the market value of Abbott Laboratories compared to its peers in the Medical Devices industry.
PE Ratio
The chart displays the price to earnings (P/E) ratio for ABT in comparison to other companies of the Medical Devices industry. Currently, ABT has a PE value of 34.7. This PE ratio falls in the average range for the industry.PEG Ratio
The chart displays the price to earnings to growth (PEG) ratio for ABT in comparison to other companies of the Medical Devices industry. Currently, ABT has a PEG value of 2.2. This PEG ratio is much higher than those of other companies of the industry. This might be an indicator of the company being overvalued.Historical P/E Ratio Chart
The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Abbott Laboratories.
Loading data...
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |